{"abstract": "A group of investors seem quite cheered by Euthymics Bioscience\u2019s prospects, ponying up $24 million in a first round of funding for the developer of next-generation antidepressants.", "web_url": "https://dealbook.nytimes.com/2010/07/23/antidepressant-maker-taps-24-million/", "snippet": "A group of investors seem quite cheered by Euthymics Bioscience\u2019s prospects, ponying up $24 million in a first round of funding for the developer of next-generation antidepressants.", "lead_paragraph": "A group of investors seem quite cheered by Euthymics Bioscience\u2018s prospects, ponying up $24 million in a first round of financing for the developer of next-generation antidepressants.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Antidepressant Maker Taps $24 Million", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "organizations", "value": "Novartis AG", "rank": 1, "major": "N"}, {"name": "organizations", "value": "State of Wisconsin Investment Board", "rank": 2, "major": "N"}], "pub_date": "2010-07-23T11:37:44+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Dealbook", "person": [{"firstname": "Dealbook", "middlename": null, "lastname": "", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "", "_id": "nyt://article/4c6c5174-aa9e-52f2-bd6d-269b9abd818d", "word_count": 74, "uri": "nyt://article/4c6c5174-aa9e-52f2-bd6d-269b9abd818d"}